Advertisement

Index by Author

November 1999; 22 (11)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Abraham, M R

    • Lispro in the treatment of insulin allergy. Diabetes Care November 1999 22:1916-1917; doi:10.2337/diacare.22.11.1916

  2. Ahrén, B

    • The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy. Diabetes Care November 1999 22:1913-1914; doi:10.2337/diacare.22.11.1913

  3. Alexander, C M

    • Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care November 1999 22:1771-1778; doi:10.2337/diacare.22.11.1771

  4. al-Sharafi, B A

    • Lispro in the treatment of insulin allergy. Diabetes Care November 1999 22:1916-1917; doi:10.2337/diacare.22.11.1916

B

  1. Bergstrom, R W

    • Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care November 1999 22:1808-1812; doi:10.2337/diacare.22.11.1808

  2. Berntorp, K

    • Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes. Diabetes Care November 1999 22:1907-1908; doi:10.2337/diacare.22.11.1907

  3. Bingley, P J

    • Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care November 1999 22:1796-1801; doi:10.2337/diacare.22.11.1796

  4. Bjørndal, A

    • Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care November 1999 22:1813-1820; doi:10.2337/diacare.22.11.1813

  5. Bloomgarden, Z T

    • American Diabetes Association Annual Meeting, 1999. New approaches to type 1 diabetes. Diabetes Care November 1999 22:1899-1903; doi:10.2337/diacare.22.11.1899

  6. Boccuzzi, S J

    • Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care November 1999 22:1771-1778; doi:10.2337/diacare.22.11.1771

  7. Boer, J M

    • Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes. Diabetes Care November 1999 22:1919; doi:10.2337/diacare.22.11.1919b

  8. Boland, E A

    • Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care November 1999 22:1779-1784; doi:10.2337/diacare.22.11.1779

  9. Boulton, A J

    • Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes. Diabetes Care November 1999 22:1839-1844; doi:10.2337/diacare.22.11.1839

  10. Bourguignon, J P

    • Cardiac autonomic dysfunction in diabetic children. Diabetes Care November 1999 22:1845-1850; doi:10.2337/diacare.22.11.1845

  11. Boyko, E J

    • Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care November 1999 22:1808-1812; doi:10.2337/diacare.22.11.1808

  12. Bretzel, R

    • Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care November 1999 22:1832-1838; doi:10.2337/diacare.22.11.1832

  13. Burcus, N

    • Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes. Diabetes Care November 1999 22:1839-1844; doi:10.2337/diacare.22.11.1839

C

  1. Caballero, A E

    • Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care November 1999 22:1865-1870; doi:10.2337/diacare.22.11.1865

  2. Cacciatori, V

    • Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients. Diabetes Care November 1999 22:1871-1874; doi:10.2337/diacare.22.11.1871

  3. Cagliero, E

    • Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care November 1999 22:1785-1789; doi:10.2337/diacare.22.11.1785

  4. Campistol, J M

    • Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care November 1999 22:1915-1916; doi:10.2337/diacare.22.11.1915

  5. Cases, A

    • Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care November 1999 22:1915-1916; doi:10.2337/diacare.22.11.1915

  6. Castenfors, J

    • Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes. Diabetes Care November 1999 22:1907-1908; doi:10.2337/diacare.22.11.1907

  7. Cervantes Aguayo, F C

    • Diabetic retinopathy and risk of blindness in Mexico. Are we doing enough? Diabetes Care November 1999 22:1905; doi:10.2337/diacare.22.11.1905

  8. Chan, J C

    • Use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of diabetes in a community. Diabetes Care November 1999 22:1908-1909; doi:10.2337/diacare.22.11.1908

  9. Chen, K W

    • Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care November 1999 22:1808-1812; doi:10.2337/diacare.22.11.1808

  10. Clària, J

    • Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care November 1999 22:1915-1916; doi:10.2337/diacare.22.11.1915

  11. Claudi, T

    • Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care November 1999 22:1813-1820; doi:10.2337/diacare.22.11.1813

  12. Cockram, C S

    • Use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of diabetes in a community. Diabetes Care November 1999 22:1908-1909; doi:10.2337/diacare.22.11.1908

  13. Cook, J R

    • Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care November 1999 22:1771-1778; doi:10.2337/diacare.22.11.1771

D

  1. Davis, J L

    • Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care November 1999 22:1909-1910; doi:10.2337/diacare.22.11.1909

  2. Dellon, A L

    • Insulin resistance. Does it play a role in peripheral neuropathy? Diabetes Care November 1999 22:1914-1915; doi:10.2337/diacare.22.11.1914

  3. Derkenne, B

    • Cardiac autonomic dysfunction in diabetic children. Diabetes Care November 1999 22:1845-1850; doi:10.2337/diacare.22.11.1845

  4. Doi, K

    • Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis. Diabetes Care November 1999 22:1911-1912; doi:10.2337/diacare.22.11.1911

  5. Dost, A

    • Physical activity and competitive sports in children and adolescents with type 1 diabetes. Diabetes Care November 1999 22:1904-1905; doi:10.2337/diacare.22.11.1904

E

  1. Emoto, M

    • Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care November 1999 22:1851-1857; doi:10.2337/diacare.22.11.1851
    • Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care November 1999 22:1858-1864; doi:10.2337/diacare.22.11.1858

  2. Ernould, C

    • Cardiac autonomic dysfunction in diabetic children. Diabetes Care November 1999 22:1845-1850; doi:10.2337/diacare.22.11.1845

  3. Esmatjes, E

    • Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care November 1999 22:1915-1916; doi:10.2337/diacare.22.11.1915

F

  1. Fernlund, P

    • Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes. Diabetes Care November 1999 22:1907-1908; doi:10.2337/diacare.22.11.1907

  2. Feskens, E J

    • Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes. Diabetes Care November 1999 22:1919; doi:10.2337/diacare.22.11.1919b

  3. Flores, L

    • Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care November 1999 22:1915-1916; doi:10.2337/diacare.22.11.1915

  4. Fredrickson, L

    • Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care November 1999 22:1779-1784; doi:10.2337/diacare.22.11.1779

  5. Fujimoto, W Y

    • Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care November 1999 22:1808-1812; doi:10.2337/diacare.22.11.1808

  6. Fukushima, M

    • Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis. Diabetes Care November 1999 22:1911-1912; doi:10.2337/diacare.22.11.1911

G

  1. Gale, E A

    • Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care November 1999 22:1796-1801; doi:10.2337/diacare.22.11.1796

  2. Gappmayer, B

    • Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care November 1999 22:1882-1886; doi:10.2337/diacare.22.11.1882

  3. Glasgow, R E

    • Smoking and diabetes. Diabetes Care November 1999 22:1887-1898; doi:10.2337/diacare.22.11.1887

  4. Gottsäter, A

    • The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy. Diabetes Care November 1999 22:1913-1914; doi:10.2337/diacare.22.11.1913

  5. Grey, M

    • Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care November 1999 22:1779-1784; doi:10.2337/diacare.22.11.1779

  6. Guerriero, A

    • Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients. Diabetes Care November 1999 22:1871-1874; doi:10.2337/diacare.22.11.1871

H

  1. Haberbosch, W

    • Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care November 1999 22:1832-1838; doi:10.2337/diacare.22.11.1832

  2. Haire-Joshu, D

    • Smoking and diabetes. Diabetes Care November 1999 22:1887-1898; doi:10.2337/diacare.22.11.1887

  3. Henderson, J A

    • Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care November 1999 22:1802-1807; doi:10.2337/diacare.22.11.1802

  4. Henricsson, M

    • Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes. Diabetes Care November 1999 22:1907-1908; doi:10.2337/diacare.22.11.1907

  5. Herman, W H

    • Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care November 1999 22:1771-1778; doi:10.2337/diacare.22.11.1771

  6. Hiddessen, A

    • Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care November 1999 22:1832-1838; doi:10.2337/diacare.22.11.1832

  7. Holmen, J

    • Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care November 1999 22:1813-1820; doi:10.2337/diacare.22.11.1813

  8. Horton, E S

    • Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care November 1999 22:1865-1870; doi:10.2337/diacare.22.11.1865

  9. Hosoi, M

    • Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care November 1999 22:1858-1864; doi:10.2337/diacare.22.11.1858

  10. Howard, B V

    • Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care November 1999 22:1802-1807; doi:10.2337/diacare.22.11.1802

  11. Hu, D

    • Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care November 1999 22:1802-1807; doi:10.2337/diacare.22.11.1802

  12. Hunkert, F

    • Physical activity and competitive sports in children and adolescents with type 1 diabetes. Diabetes Care November 1999 22:1904-1905; doi:10.2337/diacare.22.11.1904

I

  1. Ikeda, Y

    • Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI. Diabetes Care November 1999 22:1917-1918; doi:10.2337/diacare.22.11.1917

  2. Iñigo, P

    • Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care November 1999 22:1915-1916; doi:10.2337/diacare.22.11.1915

J

  1. Jablonski, K A

    • Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care November 1999 22:1790-1795; doi:10.2337/diacare.22.11.1790
    • Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care November 1999 22:1802-1807; doi:10.2337/diacare.22.11.1802

K

  1. Kanda, H

    • Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care November 1999 22:1851-1857; doi:10.2337/diacare.22.11.1851

  2. Kapellen, T

    • Physical activity and competitive sports in children and adolescents with type 1 diabetes. Diabetes Care November 1999 22:1904-1905; doi:10.2337/diacare.22.11.1904

  3. Kartnig, I

    • Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care November 1999 22:1882-1886; doi:10.2337/diacare.22.11.1882

  4. Kasuga, A

    • Diet therapy improved ketosis without insulin therapy in a case of anti-GAD65+ diabetes. Diabetes Care November 1999 22:1910-1911; doi:10.2337/diacare.22.11.1910

  5. Katoh, J

    • Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI. Diabetes Care November 1999 22:1917-1918; doi:10.2337/diacare.22.11.1917

  6. Kawagishi, T

    • Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care November 1999 22:1851-1857; doi:10.2337/diacare.22.11.1851
    • Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care November 1999 22:1858-1864; doi:10.2337/diacare.22.11.1858

  7. Kawaguchi, A

    • Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI. Diabetes Care November 1999 22:1917-1918; doi:10.2337/diacare.22.11.1917

  8. Kazumi, T

    • Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI. Diabetes Care November 1999 22:1917-1918; doi:10.2337/diacare.22.11.1917

  9. Khardori, R

    • Lispro in the treatment of insulin allergy. Diabetes Care November 1999 22:1916-1917; doi:10.2337/diacare.22.11.1916

  10. Kiess, W

    • Physical activity and competitive sports in children and adolescents with type 1 diabetes. Diabetes Care November 1999 22:1904-1905; doi:10.2337/diacare.22.11.1904

  11. Kishi, K

    • Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI. Diabetes Care November 1999 22:1917-1918; doi:10.2337/diacare.22.11.1917

  12. Kjekshus, J

    • Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care November 1999 22:1771-1778; doi:10.2337/diacare.22.11.1771

  13. Kogawa, K

    • Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care November 1999 22:1858-1864; doi:10.2337/diacare.22.11.1858

  14. Ko, G T

    • Use of a paired value of fasting plasma glucose and glycated hemoglobin in predicting the likelihood of diabetes in a community. Diabetes Care November 1999 22:1908-1909; doi:10.2337/diacare.22.11.1908

  15. Kromhout, D

    • Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes. Diabetes Care November 1999 22:1919; doi:10.2337/diacare.22.11.1919b

  16. Krüger, O

    • Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care November 1999 22:1813-1820; doi:10.2337/diacare.22.11.1813

L

  1. Lario, S

    • Smoking increases serum levels of transforming growth factor-beta in diabetic patients. Diabetes Care November 1999 22:1915-1916; doi:10.2337/diacare.22.11.1915

  2. Lebrethon, M C

    • Cardiac autonomic dysfunction in diabetic children. Diabetes Care November 1999 22:1845-1850; doi:10.2337/diacare.22.11.1845

  3. Lee, E T

    • Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care November 1999 22:1802-1807; doi:10.2337/diacare.22.11.1802

  4. Lee, R H

    • Insulin resistance. Does it play a role in peripheral neuropathy? Diabetes Care November 1999 22:1914-1915; doi:10.2337/diacare.22.11.1914

  5. Leonetti, D L

    • Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care November 1999 22:1808-1812; doi:10.2337/diacare.22.11.1808

  6. Levetan, C S

    • Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care November 1999 22:1790-1795; doi:10.2337/diacare.22.11.1790

  7. Levina, E V

    • Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care November 1999 22:1785-1789; doi:10.2337/diacare.22.11.1785

  8. Lev-Ran, A

    • Spontaneous recovery of severe weight loss in diabetic amyotrophy. Diabetes Care November 1999 22:1906-1907; doi:10.2337/diacare.22.11.1906

  9. Lim, S C

    • Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care November 1999 22:1865-1870; doi:10.2337/diacare.22.11.1865

  10. Lipp, R W

    • Is gastroparesis in diabetes cured by gastrectomy? Diabetes Care November 1999 22:1920-1921; doi:10.2337/diacare.22.11.1920

  11. LoGerfo, F W

    • Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care November 1999 22:1865-1870; doi:10.2337/diacare.22.11.1865

M

  1. Maekawa, K

    • Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care November 1999 22:1851-1857; doi:10.2337/diacare.22.11.1851

  2. Magee, M F

    • Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care November 1999 22:1802-1807; doi:10.2337/diacare.22.11.1802

  3. Magnus, P

    • Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care November 1999 22:1813-1820; doi:10.2337/diacare.22.11.1813

  4. Malik, R A

    • Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes. Diabetes Care November 1999 22:1839-1844; doi:10.2337/diacare.22.11.1839

  5. Malmberg, K

    • Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care November 1999 22:1827-1831; doi:10.2337/diacare.22.11.1827

  6. Massin, M M

    • Cardiac autonomic dysfunction in diabetic children. Diabetes Care November 1999 22:1845-1850; doi:10.2337/diacare.22.11.1845

  7. McDonnell, M E

    • Cutting the Gordian knot. Addition of metformin to insulin therapy in a patient with uncontrolled diabetes and schizophrenia. Diabetes Care November 1999 22:1912-1913; doi:10.2337/diacare.22.11.1912

  8. Midthjell, K

    • Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care November 1999 22:1813-1820; doi:10.2337/diacare.22.11.1813

  9. Morii, H

    • Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care November 1999 22:1851-1857; doi:10.2337/diacare.22.11.1851
    • Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care November 1999 22:1858-1864; doi:10.2337/diacare.22.11.1858

  10. Muggeo, M

    • Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients. Diabetes Care November 1999 22:1871-1874; doi:10.2337/diacare.22.11.1871

  11. Musliner, T A

    • Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care November 1999 22:1771-1778; doi:10.2337/diacare.22.11.1771

N

  1. Nagasaka, S

    • Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis. Diabetes Care November 1999 22:1911-1912; doi:10.2337/diacare.22.11.1911

  2. Nakai, Y

    • Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis. Diabetes Care November 1999 22:1911-1912; doi:10.2337/diacare.22.11.1911

  3. Narayan, K M

    • Reducing cardiovascular complications of type 2 diabetes. A complex but achievable and affordable task. Diabetes Care November 1999 22:1769-1770; doi:10.2337/diacare.22.11.1769

  4. Nathan, D M

    • Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care November 1999 22:1785-1789; doi:10.2337/diacare.22.11.1785

  5. Newell-Morris, L

    • Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care November 1999 22:1808-1812; doi:10.2337/diacare.22.11.1808

  6. Nietzschmann, U

    • Physical activity and competitive sports in children and adolescents with type 1 diabetes. Diabetes Care November 1999 22:1904-1905; doi:10.2337/diacare.22.11.1904

  7. Nishizawa, Y

    • Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care November 1999 22:1851-1857; doi:10.2337/diacare.22.11.1851
    • Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care November 1999 22:1858-1864; doi:10.2337/diacare.22.11.1858

  8. Nissinen, A

    • Smoking and the risk of diabetes in elderly Finnish men. Retrospective analysis of data from a 30-year follow-up study. Diabetes Care November 1999 22:1821-1826; doi:10.2337/diacare.22.11.1821

  9. Norhammar, A M

    • Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care November 1999 22:1827-1831; doi:10.2337/diacare.22.11.1827

O

  1. Obermayer-Pietsch, B

    • Is gastroparesis in diabetes cured by gastrectomy? Diabetes Care November 1999 22:1920-1921; doi:10.2337/diacare.22.11.1920

  2. Oesterle, A

    • Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care November 1999 22:1779-1784; doi:10.2337/diacare.22.11.1779

P

  1. Passaro, M D

    • Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care November 1999 22:1790-1795; doi:10.2337/diacare.22.11.1790

  2. Pedersen, T R

    • Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care November 1999 22:1771-1778; doi:10.2337/diacare.22.11.1771

  3. Perlmuter, L C

    • Considering psychosocial variables in evaluating assessments of glycemic control. Diabetes Care November 1999 22:1918-1919; doi:10.2337/diacare.22.11.1918

  4. Perry, I J

    • Impaired fasting glucose and cardiovascular disease. Diabetes Care November 1999 22:1919-1920; doi:10.2337/diacare.22.11.1919a

  5. Pittenger, G L

    • Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes. Diabetes Care November 1999 22:1839-1844; doi:10.2337/diacare.22.11.1839

  6. Poehlman, E T

    • Sex hormone-binding globulin levels in middle-aged premenopausal women. Associations with visceral obesity and metabolic profile. Diabetes Care November 1999 22:1875-1881; doi:10.2337/diacare.22.11.1875

  7. Pyörälä, K

    • Effect of simvastatin treatment on cardiovascular resource utilization in impaired fasting glucose and diabetes. Findings from the Scandinavian Simvastatin Survival Study. Diabetes Care November 1999 22:1771-1778; doi:10.2337/diacare.22.11.1771

Q

  1. Qiao, Q

    • Smoking and the risk of diabetes in elderly Finnish men. Retrospective analysis of data from a 30-year follow-up study. Diabetes Care November 1999 22:1821-1826; doi:10.2337/diacare.22.11.1821

R

  1. Raile, K

    • Physical activity and competitive sports in children and adolescents with type 1 diabetes. Diabetes Care November 1999 22:1904-1905; doi:10.2337/diacare.22.11.1904

  2. Ramíez Barba, E J

    • Diabetic retinopathy and risk of blindness in Mexico. Are we doing enough? Diabetes Care November 1999 22:1905; doi:10.2337/diacare.22.11.1905

  3. Raskin, L

    • Spontaneous recovery of severe weight loss in diabetic amyotrophy. Diabetes Care November 1999 22:1906-1907; doi:10.2337/diacare.22.11.1906

  4. Ratner, R E

    • Effect of physician specialty on outcomes in diabetic ketoacidosis. Diabetes Care November 1999 22:1790-1795; doi:10.2337/diacare.22.11.1790

  5. Ritsema, M J

    • Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes. Diabetes Care November 1999 22:1919; doi:10.2337/diacare.22.11.1919b

  6. Robbins, D C

    • Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care November 1999 22:1802-1807; doi:10.2337/diacare.22.11.1802

  7. Rocour-Brumioul, D

    • Cardiac autonomic dysfunction in diabetic children. Diabetes Care November 1999 22:1845-1850; doi:10.2337/diacare.22.11.1845

  8. Rodríguez Villalobos, E

    • Diabetic retinopathy and risk of blindness in Mexico. Are we doing enough? Diabetes Care November 1999 22:1905; doi:10.2337/diacare.22.11.1905

  9. Roller, R E

    • Is gastroparesis in diabetes cured by gastrectomy? Diabetes Care November 1999 22:1920-1921; doi:10.2337/diacare.22.11.1920

  10. Ruderman, N B

    • Cutting the Gordian knot. Addition of metformin to insulin therapy in a patient with uncontrolled diabetes and schizophrenia. Diabetes Care November 1999 22:1912-1913; doi:10.2337/diacare.22.11.1912

  11. Rydén, L

    • Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care November 1999 22:1827-1831; doi:10.2337/diacare.22.11.1827

S

  1. Saavedra, G A

    • Lispro in the treatment of insulin allergy. Diabetes Care November 1999 22:1916-1917; doi:10.2337/diacare.22.11.1916

  2. Sakai, M

    • Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis. Diabetes Care November 1999 22:1911-1912; doi:10.2337/diacare.22.11.1911

  3. Saruta, T

    • Diet therapy improved ketosis without insulin therapy in a case of anti-GAD65+ diabetes. Diabetes Care November 1999 22:1910-1911; doi:10.2337/diacare.22.11.1910

  4. Savage, P J

    • Reducing cardiovascular complications of type 2 diabetes. A complex but achievable and affordable task. Diabetes Care November 1999 22:1769-1770; doi:10.2337/diacare.22.11.1769

  5. Schnedl, W J

    • Is gastroparesis in diabetes cured by gastrectomy? Diabetes Care November 1999 22:1920-1921; doi:10.2337/diacare.22.11.1920

  6. Schnoell, F

    • Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care November 1999 22:1882-1886; doi:10.2337/diacare.22.11.1882

  7. Schweiger, A

    • Physical activity and competitive sports in children and adolescents with type 1 diabetes. Diabetes Care November 1999 22:1904-1905; doi:10.2337/diacare.22.11.1904

  8. Shimada, A

    • Diet therapy improved ketosis without insulin therapy in a case of anti-GAD65+ diabetes. Diabetes Care November 1999 22:1910-1911; doi:10.2337/diacare.22.11.1910

  9. Shofer, J B

    • Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care November 1999 22:1808-1812; doi:10.2337/diacare.22.11.1808

  10. Shoji, T

    • Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care November 1999 22:1851-1857; doi:10.2337/diacare.22.11.1851
    • Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care November 1999 22:1858-1864; doi:10.2337/diacare.22.11.1858

  11. Smakowski, P

    • Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care November 1999 22:1865-1870; doi:10.2337/diacare.22.11.1865

  12. Smith, R L

    • Painful peripheral diabetic neuropathy treated with venlafaxine HCl extended release capsules. Diabetes Care November 1999 22:1909-1910; doi:10.2337/diacare.22.11.1909

  13. Steen-Müller, M K

    • Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care November 1999 22:1832-1838; doi:10.2337/diacare.22.11.1832

  14. Sundkvist, G

    • Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes. Diabetes Care November 1999 22:1907-1908; doi:10.2337/diacare.22.11.1907
    • The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy. Diabetes Care November 1999 22:1913-1914; doi:10.2337/diacare.22.11.1913

  15. Suzuki, R

    • Diet therapy improved ketosis without insulin therapy in a case of anti-GAD65+ diabetes. Diabetes Care November 1999 22:1910-1911; doi:10.2337/diacare.22.11.1910

  16. Szelag, B

    • Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes. Diabetes Care November 1999 22:1907-1908; doi:10.2337/diacare.22.11.1907

T

  1. Tallsund, M

    • Cardiac autonomic dysfunction in diabetic children. Diabetes Care November 1999 22:1845-1850; doi:10.2337/diacare.22.11.1845

  2. Tamborlane, W V

    • Continuous subcutaneous insulin infusion. A new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care November 1999 22:1779-1784; doi:10.2337/diacare.22.11.1779

  3. Tanaka, H

    • Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis. Diabetes Care November 1999 22:1911-1912; doi:10.2337/diacare.22.11.1911

  4. Taniguchi, A

    • Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis. Diabetes Care November 1999 22:1911-1912; doi:10.2337/diacare.22.11.1911

  5. Taniwaki, H

    • Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care November 1999 22:1851-1857; doi:10.2337/diacare.22.11.1851
    • Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes. Diabetes Care November 1999 22:1858-1864; doi:10.2337/diacare.22.11.1858

  6. Targher, G

    • Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients. Diabetes Care November 1999 22:1871-1874; doi:10.2337/diacare.22.11.1871

  7. Tchernof, A

    • Sex hormone-binding globulin levels in middle-aged premenopausal women. Associations with visceral obesity and metabolic profile. Diabetes Care November 1999 22:1875-1881; doi:10.2337/diacare.22.11.1875

  8. Tibbs, T L

    • Smoking and diabetes. Diabetes Care November 1999 22:1887-1898; doi:10.2337/diacare.22.11.1887

  9. Tillmanns, H

    • Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care November 1999 22:1832-1838; doi:10.2337/diacare.22.11.1832

  10. Tokuyama, K

    • Homeostasis model assessment as a clinical index of insulin resistance. Comparison with the minimal model analysis. Diabetes Care November 1999 22:1911-1912; doi:10.2337/diacare.22.11.1911

  11. Toth, M J

    • Sex hormone-binding globulin levels in middle-aged premenopausal women. Associations with visceral obesity and metabolic profile. Diabetes Care November 1999 22:1875-1881; doi:10.2337/diacare.22.11.1875

  12. Tuomilehto, J

    • Smoking and the risk of diabetes in elderly Finnish men. Retrospective analysis of data from a 30-year follow-up study. Diabetes Care November 1999 22:1821-1826; doi:10.2337/diacare.22.11.1821

  13. Tverdal, A

    • Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care November 1999 22:1813-1820; doi:10.2337/diacare.22.11.1813

V

  1. Valle, T

    • Smoking and the risk of diabetes in elderly Finnish men. Retrospective analysis of data from a 30-year follow-up study. Diabetes Care November 1999 22:1821-1826; doi:10.2337/diacare.22.11.1821

  2. van Dam, R M

    • Diabetes prevalence in offspring of elderly men with known and newly diagnosed diabetes. Diabetes Care November 1999 22:1919; doi:10.2337/diacare.22.11.1919b

  3. Vargas Salado, E

    • Diabetic retinopathy and risk of blindness in Mexico. Are we doing enough? Diabetes Care November 1999 22:1905; doi:10.2337/diacare.22.11.1905

  4. Veves, A

    • Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care November 1999 22:1865-1870; doi:10.2337/diacare.22.11.1865

  5. Vinik, A I

    • Specific fiber deficits in sensorimotor diabetic polyneuropathy correspond to cytotoxicity against neuroblastoma cells of sera from patients with diabetes. Diabetes Care November 1999 22:1839-1844; doi:10.2337/diacare.22.11.1839

  6. Voss, R

    • Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care November 1999 22:1832-1838; doi:10.2337/diacare.22.11.1832

W

  1. Waas, W

    • Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care November 1999 22:1832-1838; doi:10.2337/diacare.22.11.1832

  2. Wahl, P W

    • Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care November 1999 22:1808-1812; doi:10.2337/diacare.22.11.1808

  3. Waldecker, B

    • Type 2 diabetes and acute myocardial infarction. Angiographic findings and results of an invasive therapeutic approach in type 2 diabetic versus nondiabetic patients. Diabetes Care November 1999 22:1832-1838; doi:10.2337/diacare.22.11.1832

  4. Weitgasser, R

    • Prospective evaluation of urinary N-acetyl-beta-D-glucosaminidase with respect to macrovascular disease in elderly type 2 diabetic patients. Diabetes Care November 1999 22:1882-1886; doi:10.2337/diacare.22.11.1882

  5. Welty, T K

    • Glycemic control in diabetic American Indians. Longitudinal data from the Strong Heart Study. Diabetes Care November 1999 22:1802-1807; doi:10.2337/diacare.22.11.1802

  6. Wenzl, H H

    • Is gastroparesis in diabetes cured by gastrectomy? Diabetes Care November 1999 22:1920-1921; doi:10.2337/diacare.22.11.1920

  7. Williams, A J

    • Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials. Diabetes Care November 1999 22:1796-1801; doi:10.2337/diacare.22.11.1796

  8. Wolfsdorf, J I

    • Improving diabetes control in adolescents. Diabetes Care November 1999 22:1767-1768; doi:10.2337/diacare.22.11.1767

  9. Wroblewski, M

    • Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes. Diabetes Care November 1999 22:1907-1908; doi:10.2337/diacare.22.11.1907

Y

  1. Yoshino, G

    • Fasting serum insulin concentrations are associated with QTc duration independent of serum leptin, percent body fat, and BMI. Diabetes Care November 1999 22:1917-1918; doi:10.2337/diacare.22.11.1917

Z

  1. Zoppini, G

    • Chronic cigarette smoking is associated with increased plasma circulating intercellular adhesion molecule 1 levels in young type 1 diabetic patients. Diabetes Care November 1999 22:1871-1874; doi:10.2337/diacare.22.11.1871

Current Issue

  1. February 2012, 35 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes Care
Advertisement